Navigation Links
MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
Date:3/19/2009

WOONSOCKET, R.I., March 19 /PRNewswire-FirstCall/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem cells and liver cancer.

Tumor tissues are composed of a mixture of cells with some tumor cells exhibiting stem cell-like properties (cancer stem cells). Cancer stem cells are thought to play a role in a tumor's resistance to therapy. While significant progress has been made in developing cancer therapies that result in cytoreduction and thus tumor regression, the control of cancer over a longer interval and especially of metastatic disease, remains a key goal. Cancer stem cells are believed to be responsible for cancer relapse by being less sensitive to conventional therapies. Cancer stem cells may offer a unique opportunity to identify and develop a new generation of more effective anticancer agents (both small molecule therapeutics and biotherapies).

MultiCell owns exclusive rights to two issued U.S. patents (6,872,389 and 6,129,911), one U.S. patent application (U.S. 2006/0019387A1), and several corresponding issued and pending foreign patents and patent applications related to the isolation and differentiation of liver stem cells. The role of liver stem cells in the carcinogenic process has recently led to a new hypothesis that hepatocellular carcinoma arises by maturation arrest of liver stem cells.

Primary liver cancer begins in the cells of the liver itself. According to the National Cancer Institute (NCI), in 2008 there were approximately 21,400 new cases of primary liver cancer and intrahepatic bile duct cancer in the United States, and approximately 18,400 of those cases resulted in death. Hepatocellular carcinoma, resulting from Hepatitis B and Hepatitis C infection, is the most common cancer in some parts of the world, wit
'/>"/>

SOURCE MultiCell Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
2. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
3. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
4. Neuro Kinetics: Research Suggests I-Portal(R) NOTC Data Shows Mild Traumatic Brain Injuries That Other Technologies Miss
5. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
6. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
7. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
8. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
9. ImmunoVaccine Technologies DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases
10. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
11. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CLEVELAND , July 10, 2014  The U.S. ... a three-year grant to University Hospitals (UH) Case Medical ... a new national model aimed at improving care for ... Oncology Care," the project will test a unique model ... patients with late-stage disease, significant comorbidities, or demonstrated need ...
(Date:7/10/2014)... 10, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year ended June 30, 2014 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, Inc. ... announced it has completed the sale to Galderma of ... owned or held by Valeant for $1.4 billion in ... S.A, which recently completed its acquisition of Galderma. ... of our products to a company that is firmly ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... Today, Siemens (NYSE: SI ) announces ... Medical Informatics Officer (CMIO), of the Health Services (HS) Business ... Health Information Exchange (IHIE), Marc recently served as ... role at Siemens, Marc will be responsible for clinical informatics ...
... 21, 2011 From the floor of the HIMSS11 ... MDRX ) today demonstrated native integration between its ... (EHR) and the Allscripts Enterprise and ... (Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 2Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 3Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 4Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 5
(Date:7/11/2014)... July 11, 2014 Datalogic brings a ... improving sanitation hospital wide. With their new Gryphon ... of disease, like the devastating MRSA, which claimed 5,500 ... GD4400-HC 2D and the Gryphon GM4400-HC 2D ... and can even read barcodes off of troublesome LCD ...
(Date:7/11/2014)... Operators and owners stand ... fuel costs now that model 2019 will ... standards are phasing in 2014-2018 standards. ... to install new features into their vehicles ... , 2.    Efficient driveline components which reduce friction ...
(Date:7/11/2014)... (HealthDay News) -- Children who have emergency surgery ... and potentially even death than those who have ... However, the Johns Hopkins researchers noted that the ... analyzed data on nearly 440,000 simple emergency surgeries ... a 22-year period. The surgeries are considered ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... comes to the summer concert schedule, it just isn’t complete without ... of the biggest names in country music and one of the ... his “That’s My Kind of Night” tour featuring Lee Brice and ... through the rest of the summer and into the fall includes ...
(Date:7/11/2014)... Stamford, CT (PRWEB) July 11, 2014 ... – the nation’s only non-profit dedicated exclusively to ... announced that Joshua Corday has joined the organization ... veteran fundraising professional with deep experience securing gifts ... he served as Annual Giving Director for NewYork ...
Breaking Medicine News(10 mins):Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 3
... lowers bleeding risk for patients undergoing bypass, study finds ... kind of anticlotting drug is safe over the long ... attacks. , The drug, a "direct thrombin inhibitor" called ... cardiac procedures such as bypass surgery. , "We had ...
... carried out by researchers at the Kyoto University School ... CELL TRANSPLANTATION (Vol.16 No. 8) has shown that when ... are protected by a 15mm silicon tube and nourished ... The research may provide an important step in developing ...
... Dec. 4 Dennis D. Spencer, M.D., Chair ... was elected,President of the 3,000 member American Epilepsy ... Philadelphia. AES is the professional,society for physicians and ... Spencer is internationally recognized in the surgical treatment ...
... Moms Can Win a Free Year,s Supply of Milk!, ... dinner,table, what was once a staple of the meal -- ... milk at dinner has steadily declined, and today,nearly 60 percent ... The NPD Group(1). Conversely, nearly one-third of all kids,meals are ...
... than one in ten infants in the U.S. is ... associated with premature births is brittle bones, or osteopenia of ... the infant, and osteoporosis later in life. , Tel ... aims to make preemies bones stronger. Dr. Dan Nemet and ...
... surveys and 100 covertly recorded visits by actors ... in many exam rooms around the Rochester, N.Y., ... are viewed as more trustworthy. , The study, ... Medicine at the University of Rochester Medical Center, ...
Cached Medicine News:Health News:Newer Anticlotting Drug Safe, Effective for Heart Surgeries 2Health News:Newer Anticlotting Drug Safe, Effective for Heart Surgeries 3Health News:Bone marrow cell transplants help nerve regeneration 2Health News:Dietitians Urge Parents to Serve 'Milk With Meals' 2Health News:Dietitians Urge Parents to Serve 'Milk With Meals' 3Health News:Tel Aviv University gives preemies a fighting chance 2Health News:Patients wonder, 'Could this be something serious?' 2Health News:Patients wonder, 'Could this be something serious?' 3
... the world's first directly illuminated, hand-held ... tradition of bringing superior ophthalmic technology ... keeping with that tradition, Welch Allyn ... Ophthalmoscope. With its newly designed precision ...
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
... ALE-3600 and ALE-3600PC Patternless ... fit lenses to frames, ... the convenience of complete ... edgers are particularly suited ...
... FR-20M offers all the features of the FR-20 ... tracing. Now, you no longer need to connect ... The FR-20M is capable of receiving data via ... location, allowing you to streamline your edging operations. ...
Medicine Products: